PAX6 and central nervous system cancer: Moreover, we discovered that PAX6 expression showed negative correlations with GPX4, a key ferroptosis-regulating enzyme, while enhancing lipid peroxides (LPOs) and inhibiting glutathione (GSH) synthesis, which demonstrated that PAX6 could inhibit the malignant progression of glioma cells by activating the ferroptosis pathway at the molecular level.